Treatment of Long COVID with Anxiety or Depressive Symptoms

Clinical Scenario

This protocol applies to patients with post-COVID-19 condition (long COVID) who present with anxiety or depressive symptoms. Managing these psychiatric symptoms alongside long COVID requires a structured, evidence-based clinical approach.

Long COVID Anxiety Depressive symptoms

Management Approach

The approach for long COVID presenting with anxiety or depressive symptoms involves structured assessment of symptom severity, including evaluation of risk. Depending on the clinical picture, psychiatric consultation and pharmacological management for depressive symptoms may be part of the pathway.

The full protocol specifies the exact clinical thresholds, decision criteria, and sequencing — including the conditions that determine when and how each intervention is indicated. This detail is available in the complete structured regimen below.

The complete clinical sequence is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3947/ic.2024.0024

If there are severe psychiatric symptoms or a risk of self-harm or suicide, immediate psychiatric consultation is recommended (G, I).

When a patient with long COVID exhibits depressive symptoms, the prescription of selective serotonin reuptake inhibitors (SSRIs) may be considered (C, IIb).

View source ↗